Literature DB >> 28808966

Methods to Visualize MAVS Subcellular Localization.

Christine Vazquez1, Dia C Beachboard1, Stacy M Horner2,3.   

Abstract

The mitochondrial antiviral signaling (MAVS) protein is a central adaptor protein required for antiviral innate immune signaling. To facilitate its roles in innate immunity, MAVS localizes to multiple intracellular membranous compartments, including the mitochondria, the mitochondrial-associated ER membrane (MAM), and peroxisomes. Studies of MAVS function therefore often require an analysis of MAVS localization. To detect MAVS protein on intracellular membranes, biochemical fractionation to isolate MAMs, mitochondria, or peroxisomes can be used. Further, immunofluorescence with antibodies against specific membrane markers can be used to visualize MAVS distribution throughout the cell. Here, we describe the biochemical fractionation and immunofluorescence protocols used to detect MAVS subcellular localization.

Entities:  

Keywords:  Endoplasmic reticulum; Fractionation; Immunofluorescence; Interferon; MAM; MAVS; Mitochondria; Peroxisomes

Mesh:

Substances:

Year:  2017        PMID: 28808966      PMCID: PMC6103534          DOI: 10.1007/978-1-4939-7237-1_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

1.  Isolation of peroxisomes from tissues and cells by differential and density gradient centrifugation.

Authors:  J M Graham
Journal:  Curr Protoc Cell Biol       Date:  2001-05

2.  Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF.

Authors:  Kui Li; Eileen Foy; Josephine C Ferreon; Mitsuyasu Nakamura; Allan C M Ferreon; Masanori Ikeda; Stuart C Ray; Michael Gale; Stanley M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

Review 3.  MAVS Coordination of Antiviral Innate Immunity.

Authors:  Christine Vazquez; Stacy M Horner
Journal:  J Virol       Date:  2015-05-06       Impact factor: 5.103

4.  Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus.

Authors:  Etienne Meylan; Joseph Curran; Kay Hofmann; Darius Moradpour; Marco Binder; Ralf Bartenschlager; Jürg Tschopp
Journal:  Nature       Date:  2005-09-21       Impact factor: 49.962

5.  Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus.

Authors:  Stacy M Horner; Helene Minyi Liu; Hae Soo Park; Jessica Briley; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-15       Impact factor: 11.205

6.  IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction.

Authors:  Taro Kawai; Ken Takahashi; Shintaro Sato; Cevayir Coban; Himanshu Kumar; Hiroki Kato; Ken J Ishii; Osamu Takeuchi; Shizuo Akira
Journal:  Nat Immunol       Date:  2005-08-28       Impact factor: 25.606

7.  Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3.

Authors:  Rashu B Seth; Lijun Sun; Chee-Kwee Ea; Zhijian J Chen
Journal:  Cell       Date:  2005-09-09       Impact factor: 41.582

8.  Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection.

Authors:  Yueh-Ming Loo; David M Owen; Kui Li; Andrea K Erickson; Cynthia L Johnson; Penny M Fish; D Spencer Carney; Ting Wang; Hisashi Ishida; Mitsutoshi Yoneyama; Takashi Fujita; Takeshi Saito; William M Lee; Curt H Hagedorn; Daryl T-Y Lau; Steven A Weinman; Stanley M Lemon; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

9.  Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity.

Authors:  Xiao-Dong Li; Lijun Sun; Rashu B Seth; Gabriel Pineda; Zhijian J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-21       Impact factor: 11.205

10.  Proteomic analysis of mitochondrial-associated ER membranes (MAM) during RNA virus infection reveals dynamic changes in protein and organelle trafficking.

Authors:  Stacy M Horner; Courtney Wilkins; Samantha Badil; Jason Iskarpatyoti; Michael Gale
Journal:  PLoS One       Date:  2015-03-03       Impact factor: 3.240

View more
  5 in total

1.  BBIT20 inhibits homologous DNA repair with disruption of the BRCA1-BARD1 interaction in breast and ovarian cancer.

Authors:  Liliana Raimundo; Angela Paterna; Juliana Calheiros; Joana Ribeiro; David S P Cardoso; Ilaria Piga; Susana Junqueira Neto; Denise Hegan; Peter M Glazer; Stefano Indraccolo; Silva Mulhovo; José Luís Costa; Maria-José U Ferreira; Lucília Saraiva
Journal:  Br J Pharmacol       Date:  2021-06-11       Impact factor: 9.473

2.  Peroxisomes in host defense.

Authors:  Francesca Di Cara
Journal:  PLoS Pathog       Date:  2020-07-02       Impact factor: 6.823

Review 3.  Peroxisomes in Immune Response and Inflammation.

Authors:  Francesca Di Cara; Pierre Andreoletti; Doriane Trompier; Anne Vejux; Margret H Bülow; Julia Sellin; Gérard Lizard; Mustapha Cherkaoui-Malki; Stéphane Savary
Journal:  Int J Mol Sci       Date:  2019-08-08       Impact factor: 5.923

4.  SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular Carcinoma.

Authors:  Sara Gomes; Bartolomeo Bosco; Joana B Loureiro; Helena Ramos; Liliana Raimundo; Joana Soares; Nair Nazareth; Valentina Barcherini; Lucília Domingues; Carla Oliveira; Alessandra Bisio; Silvano Piazza; Matthias R Bauer; João P Brás; Maria Inês Almeida; Célia Gomes; Flávio Reis; Alan R Fersht; Alberto Inga; Maria M M Santos; Lucília Saraiva
Journal:  Cancers (Basel)       Date:  2019-08-10       Impact factor: 6.639

5.  Targeted Mitochondrial Therapy With Over-Expressed MAVS Protein From Mesenchymal Stem Cells: A New Therapeutic Approach for COVID-19.

Authors:  Amirhesam Babajani; Pooya Hosseini-Monfared; Samin Abbaspour; Elham Jamshidi; Hassan Niknejad
Journal:  Front Cell Dev Biol       Date:  2021-06-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.